151 results
DEFM14A
KDNY
Chinook Therapeutics Inc
10 Jul 23
Proxy related to merger
4:01pm
, arbitration, hearing, litigation, audit, inquiry or investigation in each case whether civil, criminal, administrative, judicial or investigative … for the fiscal year ended December 31, 2022 to the Agreement Date, the Company’s auditors have not identified to the audit committee of the Company Board (A) any
PREM14A
KDNY
Chinook Therapeutics Inc
27 Jun 23
Preliminary proxy related to merger
4:02pm
, hearing, litigation, audit, inquiry or investigation in each case whether civil, criminal, administrative, judicial or investigative, or any appeal … December 31, 2022 to the Agreement Date, the Company’s auditors have not identified to the audit committee of the Company Board (A) any significant
DEFA14A
mm56zh 85cpq
12 Jun 23
Additional proxy soliciting materials
7:05am
8-K
EX-2.1
z401qe542n4
12 Jun 23
Chinook Therapeutics Enters into Agreement to be Acquired by Novartis AG
7:00am
PRE 14A
b360ag0t1vltktl
17 Apr 23
Preliminary proxy
4:51pm
8-K
EX-1.1
syadxnlpq a45h7o
25 May 22
Chinook Therapeutics Announces Pricing of a $105 Million Public Offering
4:09pm